Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Psychiatric Genomics Raises $17M As Part Of Series B Round

Nov. 20, 2002

By Aaron Lorenzo

Medicines Co. Presents StrongResults From Angiomax Study

Nov. 19, 2002

By Aaron Lorenzo

Medicines Co. Presents StrongResults From Angiomax Study

Nov. 19, 2002

By Aaron Lorenzo

ViroLogic Plans Cuts While It Raises $10M, Deals With Pfizer

Nov. 18, 2002

By Aaron Lorenzo

ViroLogic Plans Cuts While It Raises $10M, Deals With Pfizer

Nov. 18, 2002

By Aaron Lorenzo

Arena, Lilly Ending GPCR Deal Early After Generating Targets

Nov. 15, 2002

By Aaron Lorenzo

Scynexis, Roche Collaborate To Discover, Develop Drugs

Nov. 15, 2002

By Aaron Lorenzo

Arena, Lilly Ending GPCR Deal Early After Generating Targets

Nov. 15, 2002

By Aaron Lorenzo

Scynexis, Roche Collaborate To Discover, Develop Drugs

Nov. 15, 2002

By Aaron Lorenzo

NeoRx Licenses Technology To IDEC, Considers Others Actions

Nov. 14, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...